GLP-1 receptor agonists
US$ 29.21
glp-1 medicaid Patients Face New Barriers for Drugs Biden administration plans to expand
Description
There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)
As a health coach, Ive had more clients than I can count ask me about GLP-1 weight loss providers
Take daily for all-in-one digestive support, muscle support, & a wellness boost
*Package updating - January 2026
The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.
Cutting-Edge, Non-Medicated Wellness Delivered Through Your Skin
